Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 nov. 2020 09h24 HE | Source: XenoTherapeutics

From Pig to Patient: XenoTherapeutics Completes First Cohort of Patients in First US Clinical Trial of Live-Cell Xenotransplant; Evidence of Safety and Efficacy Allows for Accelerated Patient Enrollment

BOSTON, MA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- XenoTherapeutics, a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs, has completed the first of...
15 oct. 2020 10h03 HE | Source: XenoTherapeutics

XenoTherapeutics Granted U.S. Patent Covering Method of Producing Clinically Acceptable Porcine Cells, Tissues, and Organs for Human Xenotransplantation

BOSTON, MA, Oct. 15, 2020 (GLOBE NEWSWIRE) -- XenoTherapeutics, a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs, announced that the U.S....
26 févr. 2020 15h00 HE | Source: XenoTherapeutics

XenoTherapeutics Welcomes Michael Yaremchuk as Chief Medical Officer

Boston, Feb. 26, 2020 (GLOBE NEWSWIRE) -- XenoTherapeutics, a clinical-stage biotechnology company developing alternative gene therapies in xenotransplantation to supply living cells, tissues, and...